Literature DB >> 19938247

Genotype-phenotype analysis of TCF4 mutations causing Pitt-Hopkins syndrome shows increased seizure activity with missense mutations.

Jill A Rosenfeld1, Kathleen Leppig, Blake C Ballif, Heidi Thiese, Christine Erdie-Lalena, Erwati Bawle, Sujatha Sastry, J Edward Spence, Anne Bandholz, Urvashi Surti, Jonathan Zonana, Kory Keller, Wendy Meschino, Bassem A Bejjani, Beth S Torchia, Lisa G Shaffer.   

Abstract

PURPOSE: Pitt-Hopkins syndrome is characterized by severe mental retardation, characteristic dysmorphic features, and susceptibility to childhood-onset seizures and intermittent episodes of hyperventilation. This syndrome is caused by haploinsufficiency of TCF4, which encodes a basic helix-loop-helix transcription factor. Missense, nonsense, splice-site mutations, and gene deletions have been found in individuals with Pitt-Hopkins syndrome. Previous reports have suggested that the Pitt-Hopkins syndrome phenotype is independent of mutation or deletion type.
METHODS: We screened 13,186 individuals with microarray-based comparative genomic hybridization. We also conducted a review of the literature and statistical analysis of the phenotypic features for all individuals with confirmed mutations or deletions of TCF4.
RESULTS: We identified seven individuals with TCF4 deletions. All patients have features consistent with Pitt-Hopkins syndrome, although only three have breathing anomalies, and none has seizures. Our review of previously reported cases with TCF4 mutations and deletions showed that all patients with Pitt-Hopkins syndrome reported to date have severe psychomotor retardation, the onsets of seizures and hyperventilation episodes are limited to the first decade in most reported patients with Pitt-Hopkins syndrome, hyperventilation episodes are more common than seizures and are seen in the oldest patients, and individuals with missense TCF4 mutations are more likely to develop seizures.
CONCLUSIONS: On the basis of an analysis of published cases, we propose a genotype-phenotype correlation of increased seizure activity with missense TCF4 mutations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19938247     DOI: 10.1097/GIM.0b013e3181bd38a9

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  28 in total

Review 1.  Impact of TCF4 on the genetics of schizophrenia.

Authors:  Leonhard Lennertz; Boris B Quednow; Jens Benninghoff; Michael Wagner; Wolfgang Maier; Rainald Mössner
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-09-20       Impact factor: 5.270

Review 2.  Genetic interactions and modifier genes in Hirschsprung's disease.

Authors:  Adam S Wallace; Richard B Anderson
Journal:  World J Gastroenterol       Date:  2011-12-07       Impact factor: 5.742

Review 3.  Pitt-Hopkins Syndrome: A Review of Current Literature, Clinical Approach, and 23-Patient Case Series.

Authors:  Kimberly Goodspeed; Cassandra Newsom; Mary Ann Morris; Craig Powell; Patricia Evans; Sailaja Golla
Journal:  J Child Neurol       Date:  2018-01-10       Impact factor: 1.987

4.  The role of the TCF4 gene in the phenotype of individuals with 18q segmental deletions.

Authors:  Minire Hasi; Bridgette Soileau; Courtney Sebold; Annice Hill; Daniel E Hale; Louise O'Donnell; Jannine D Cody
Journal:  Hum Genet       Date:  2011-06-14       Impact factor: 4.132

Review 5.  Clinical review of genetic epileptic encephalopathies.

Authors:  Grace J Noh; Y Jane Tavyev Asher; John M Graham
Journal:  Eur J Med Genet       Date:  2012-01-25       Impact factor: 2.708

6.  Common Pathophysiology in Multiple Mouse Models of Pitt-Hopkins Syndrome.

Authors:  Courtney Thaxton; Alexander D Kloth; Ellen P Clark; Sheryl S Moy; Raymond A Chitwood; Benjamin D Philpot
Journal:  J Neurosci       Date:  2017-12-08       Impact factor: 6.167

7.  TCF4, schizophrenia, and Pitt-Hopkins Syndrome.

Authors:  Derek J Blake; Marc Forrest; Ria M Chapman; Caroline L Tinsley; Michael C O'Donovan; Michael J Owen
Journal:  Schizophr Bull       Date:  2010-04-26       Impact factor: 9.306

8.  Haploinsufficiency of SOX5 at 12p12.1 is associated with developmental delays with prominent language delay, behavior problems, and mild dysmorphic features.

Authors:  Allen N Lamb; Jill A Rosenfeld; Nicholas J Neill; Michael E Talkowski; Ian Blumenthal; Santhosh Girirajan; Debra Keelean-Fuller; Zheng Fan; Jill Pouncey; Cathy Stevens; Loren Mackay-Loder; Deborah Terespolsky; Patricia I Bader; Kenneth Rosenbaum; Stephanie E Vallee; John B Moeschler; Roger Ladda; Susan Sell; Judith Martin; Shawnia Ryan; Marilyn C Jones; Rocio Moran; Amy Shealy; Suneeta Madan-Khetarpal; Juliann McConnell; Urvashi Surti; Andrée Delahaye; Bénédicte Heron-Longe; Eva Pipiras; Brigitte Benzacken; Sandrine Passemard; Alain Verloes; Bertrand Isidor; Cedric Le Caignec; Gwen M Glew; Kent E Opheim; Maria Descartes; Evan E Eichler; Cynthia C Morton; James F Gusella; Roger A Schultz; Blake C Ballif; Lisa G Shaffer
Journal:  Hum Mutat       Date:  2012-04       Impact factor: 4.878

Review 9.  Epilepsy in patients with Angelman syndrome.

Authors:  Agata Fiumara; Annarita Pittalà; Mariadonatella Cocuzza; Giovanni Sorge
Journal:  Ital J Pediatr       Date:  2010-04-16       Impact factor: 2.638

Review 10.  Pitt-Hopkins Syndrome and Differential Diagnosis: A Molecular and Clinical Challenge.

Authors:  Giuseppe Marangi; Marcella Zollino
Journal:  J Pediatr Genet       Date:  2015-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.